A clinical study of Bevacizumab therapy in combination with chemotherapeutic drugs for children with recurrent glioma
Not Applicable
Recruiting
- Conditions
- recurrent malignant glioma in children
- Registration Number
- JPRN-UMIN000005528
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
The following patients must be excluded: 1)Patients taking anticoagulant agents 2)Patients with the past history of thrombosis 3)Patients with the past history of intestinal hemorrhage or lung hemorrhage 4)Past history of stereotactic radiosurgery for intracranial lesions may be included in exclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method